Expression of bcl-2 oncoprotein in transitional cell carcinoma of the upper urinary tract

Virchows Archiv

Volumn 432, Issue 5, 1998, Pages 445-450

  Nakanishi, Kuniaki ^a   Tominaga, Susumu ^a   Kawai, Toshiaki ^a   Torikata, Chikao ^a   Aurues, Takashi ^a   Ikeda, Tomosumi ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

bcl 2 oncoprotein; Transitional cell carcinoma; Upper urinary tract

Indexed keywords

CYCLINE; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; URINARY TRACT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53; URETERAL NEOPLASMS;

EID: 0031750391     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050189     Document Type: Article

References (30)

1. Akaza H,. Koiso K, Niijima T (1987) Clinical evaluation of urothelial tumors of the renal pelvis and ureter based on a new classification system. Cancer 59:1369-1375
2. Baer R (1994) Bcl-2 breathes life into embryogenesis. Am J Pathol 145:7-10
3. Baretton GB, Diebold J, Christoforis G, Vogt M, Müller C, Dopfer K, Schneiderbanger K, Schmidt M, Löhrs U (1996) Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Cancer 77:255-264
4. Bhargara V, Kell DL, van de Rijn M, Warnke RA (1994) Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol 145:535-540
5. Bubendorf L, Sauter G, Moch H, Jordan P, Blöchlinger A, Gasser TC, Mihatsch MJ (1996) Prognostic significance of bcl-2 in clinically localized prostate cancer. Am J Pathol 148:1557-1565
6. Castle VP, Heidelberger KP, Bromemberg J, Ou X, Dole M. Nunez G (1993) Expression of the apoptosis-suppressing protein bcl-2 in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol 143:1543-1550
7. Cheville JC, Terrell RB, Cohen MB (1994) Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis. Mod Pathol 7:794-800
8. Chowdhury GM, Kojima K, Kanayama H, Tsuji M, Kurokawa Y, Kagawa S (1996) The proliferation index of MIB-1 as prognostic factor for patients with transitional cell carcinoma of the upper urinary tract. Cancer 78:827-833
9. Doglioni C, Dei Tos AP, Laurino L, Chiarelli C, Barbareschi M, Viale G (1994) The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status. Virchows Arch 424:47-51
10. Furihata M, Sonobe H, Ohtsuki Y, Yamashita M, Morioka M, Yamamoto A, Terao N, Kuwahara M, Fujisaki N (1996) Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia. J Pathol (Lond) 178:133-139
11. Ginsberg D, Mechta F, Yaniv M, Oren M (1991) Wild-type p53 can down-modulate the activity of various promoters. Proc Natl Acad Sci USA 88:9979-9983
12. Haldar S, Negrini M, Monne M, Sabbioni S, Croce CM (1994) Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 54:2095-2097
13. Huben RP, Mounzer AM, Murphy GP (1988) Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer 62:2016-2020
14. King ED, Matteson J, Jacobs SC, Kyprianou N (1996) Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression. J Urol 155:316-320
15. Kuwashima Y, Uehara T, Kishi K, Shiromizu K, Mstsuzawa M, Takayama S (1994) Immunohistochemical characterization of undifferentiated carcinomas of the ovary. J Cancer Res Clin Oncol 120:672-677
16. Lauwers GY, Scott GV, Hendricks J (1994) Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia. Cancer 73:2900-2904
17. Lauwers GY, Scott GV, Karpeh MS (1995) Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer 75:2209-2213
18. Leek RD, Kaklamanis L, Pezzella F, Gatter KC, Harris AL (1994) bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer 69:135-139
19. McDonnel TJ, Troncoso P, Brisbay SM, Logothetic C, Chung LWK, Hsieh JT, Tu SM, Campbell ML (1992) Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52:6940-6944
20. Miyashita T, Harigai M, Hanada M, Reed JC (1994) Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54:3131-3136
21. Murphy WM, Beckwith JB, Furrow GM (1994) Tumors of the kidney, bladder, und related urinary structures. Atlas of tumor pathology, 3rd ser, fase 11. Armed Forces Institute of Pathology, Washington DC, pp 202-219
22. Nakamura S, Akazawa K, Kinukawa N, Yao T, Tsuneyoshi M (1996) Inverse correlation between the expression of bcl-2 and p53 protein in primary gastric lymphoma. Hum Pathol 27:225-233
23. Nakanishi K, Kawai T, Torikata C (1996) Immunohistochemical evaluation of p53 oncoprotein in transitional cell carcinoma of the upper urinary tract. Hum Pathol 27:1336-1340
24. Nakanishi K, Kawai T, Torikata C, Aurues T, Ikeda T (1997) E-cadherin in upper urinary tract carcinoma. Int J Cancer 74:446-449
25. Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Gatter KC, Mason DY (1993) Bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 329:690-694
26. Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1-6
27. SAS Institute (1991) SAS/STAT software: the PHREG procedure, version 6 (Technical report P-217). SAS Institute, Cary
28. Tsujimoto Y, Cossman J, Jaffe E, Croce CM (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science 228:1440-1443
29. UICC (International Union Against Cancer) (1992) Renal pelvis and ureter. In: Illustrated guide to the TNM/pTNM classification of malignant tumours, 3rd edn. 2nd rev. Springer, Berlin Heidelberg New York, pp 270-273
30. Viale G, Roncalli M, Grimelius L, Graziani D, Wilander E, Johansson H, Bergholm U, Coggi G (1995) Prognostic value of Bcl-2 immunoreactivity in medullary thyroid carcinoma. Hum Pathol 26:945-950